Pennsylvania Business Report
GSK agrees to acquire Nuvalent, Inc.
GSK plc, the global biopharma company with a major hub in Philadelphia, announced it has agreed to acquire Boston-based clinical-stage biopharmaceutical company, Nuvalent, Inc. Nuvalent is focused on creating precisely targeted oncology therapies, and the acquisition is in line with GSK’s strategy of acquiring assets that have validated targets and meaningfully address efficacy and/or tolerability limitations of existing standard-of-care therapies. The acquisition includes three lung ca...
Read More
Urban Outfitters expanding in two locations
June 10, 2026
Allegheny County to invest in clean technology
June 8, 2026
Orrstown Bank names Adam Metz as president, CEO
June 8, 2026
